Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

26.58
-0.6800-2.49%
Post-market: 26.640.0600+0.23%19:59 EST
Volume:41.49M
Turnover:1.11B
Market Cap:151.13B
PE:19.54
High:26.95
Open:26.72
Low:26.35
Close:27.26
52wk High:27.94
52wk Low:20.92
Shares:5.69B
Float Shares:5.68B
Volume Ratio:1.15
T/O Rate:0.73%
Dividend:1.72
Dividend Rate:6.47%
EPS(TTM):1.36
EPS(LYR):1.36
ROE:8.89%
ROA:5.68%
PB:1.75
PE(LYR):19.48

Loading ...

Scotiabank Reaffirms Their Buy Rating on Pfizer (PFE)

TIPRANKS
·
Feb 04

BREAKINGVIEWS-Novo Nordisk’s falling knife is still gathering speed

Reuters
·
Feb 04

Balanced Near-Term Pipeline Upside Versus Structural Profit Headwinds Keeps Pfizer at Hold

TIPRANKS
·
Feb 04

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Pfizer (PFE)

TIPRANKS
·
Feb 04

Pfizer veröffentlicht Transkript zur Telefonkonferenz zu den Q4-2025-Ergebnissen

Reuters
·
Feb 04

Pfizer Earnings Call: Pipeline Strength Amid COVID Reset

TIPRANKS
·
Feb 04

Pfizer (PFE.US) Reports Positive Topline Results for Ultra-Long-Acting Weight Loss Therapy, Set to Initiate Phase 3 Trials

Stock News
·
Feb 04

Health Care Down After Pfizer, Novo Nordisk Earnings -- Health Care Roundup

Dow Jones
·
Feb 04

Silver Surges Over 15%; Pfizer Earnings Top Views

Benzinga
·
Feb 04

Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE)

TIPRANKS
·
Feb 03

Pfizer Shares Extend Losses; Last Down 4.6% Premarket

THOMSON REUTERS
·
Feb 03

BRIEF-Pfizer’S Ultra-Long-Acting Injectable Glp-1 RA Shows Weight Loss Results In Phase 2B Trial

Reuters
·
Feb 03

Pfizer (PFE.US) Q4 Results Beat Expectations, But Investors Focus on Weight-Loss Drug's Growth Potential

Stock News
·
Feb 03

Strong Drug Demand Drives Pfizer's Q4 Profit Above Market Expectations

Deep News
·
Feb 03

Stock Track | Pfizer Plunges 5.06% in Pre-Market on 2026 Guidance Disappointment and Lack of Buybacks

Stock Track
·
Feb 03

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Dow Jones
·
Feb 03

Pfizer Stock Falls After Solid Earnings. What’s Troubling Wall Street

Reuters
·
Feb 03

Pfizer: on-Track to Deliver Majority of Anticipated $7.2 Bln in Total Net Cost Savings From Productivity Programs by End of 2026- Prepared Remarks

THOMSON REUTERS
·
Feb 03

Pfizer: Expect Additional Savings of $700 Mln in 2026 & $200 Mln in 2027 From Phase 1 of Manufacturing Optimization Program

THOMSON REUTERS
·
Feb 03

Pfizer Sees Additional Savings of $700 Million in 2026 and $200 Million in 2027 From Its Manufacturing Optimization Program

THOMSON REUTERS
·
Feb 03